※ Feature Articles @ ITREN 2018~2024
최근 6년간 출간된 하이라이트 논문들
46. Bioactive Mater (2024년) (IF=18.9, 상위 1.5%)
"Adaptive immunity of materials: Implications for tissue healing and regeneration"
45. Nano-Micro Lett (2024년) (IF=31.6, 상위 1%)
"Nanozyme-Engineered Hydrogels for Anti-Inflammation and Skin Regeneration"
44. Adv Sci (2024년) (IF=15, 상위 2.7%)
"Neural-Tissue-Like, not Supraphysiological, Electrical Conductivity Stimulates Neuronal Lineage Specification through Calcium Signalling and Epigenetic Modification"
43. Adv Health Mater (2024년) (IF=10, 상위 8%)
"Strontium/Silicon/Calcium-Releasing Hierarchially Structured 3D-Printed Scaffolds Accelerate Osteochondral Defect Repair"
42. Adv Sci (2024년) (IF=15, 상위 2.7%)
"Targeting Nuclear Mechanics Mitigates the Fibroblast Invasiveness in Pathological Dermal Scars Induced by Matrix Stiffening"
41. Adv Sci (2024년) (IF=15, 상위 2.7%)
"Tissue Mechanics and Hedgehog Signalling Crosstalk as a Key Epithelial-Stromal Interplay in Cancer Development
40. Adv Sci (2023년) (IF=15, 상위 2.7%)
“Cyclic stretch promotes cellular reprogramming process through cytoskeletal-nuclear mechao-coupling and epigenetic modification"
39. Adv Funct Mater (2023년) (IF=19, 상위 1.8%)
“Coordinated biophysical stimulation of MSCs via electromagnetized Au-nanofiber regulates cytoskeletal-to-nuclear mechano-responses"
38. Trends in Biotech (2023년) (IF=17.3, 상위 2.8%)
“Advanced materials technologies to unravel mechanobiological pheneomena"
37. Bioactive Mater (2023년) (IF=18.9, 상위 1.5%)
“Double hits with bioactive nanozyme based on cobalt-doped nanoglass for acute and diabetic wound therapies"
36. Prog Mater Sci (2023년) (IF=48.145, 상위 0.8%)
“Materials-based nanotherapeutics for injured and diseased bone”
35. Mater Today Bio (2023년) (IF=10.76, 상위 8.8%)
“Multifunctional dendrimer@nanoceria engineered GelMA hydrogel accerates bone regeneration through orchestrated..."
34. Chem Eng J (2023년) (IF=16.744, 상위 3%)
“Electroconductive and mechano-competent PUCL@CNT nanohybrid scaffolds guiding neural specification”
33. Biomaterials (2023년) (IF=15.304, 상위 1.7%)
“Mechano-modulation of T cells for cancer immunotherapy"
32. Matter (2022년) (IF=19.9, 상위 2%)
“Matrix-enabled mechanobiological modulation of osteoimmunology”
21. Biomaterials (2022년) (IF=15.304 , 상위 1.7%)
“Chemically-induced osteogenic cells for bone tissue engineering and disease modeling”
30. Cell Death Diff (2022년) (IF=12.073 , 상위 5.9%)
“TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis”
29. Trend Mol Med (2022년) (IF=15.272 , 상위 4.7 %)
“Leveraging cellular mechano-responsiveness for cancer therapy”
28. Adv Health Mater (2022년) (IF=11.092 , 상위 8%)
“Delivery of Induced Neural Stem Cells Through Mechano-tuned Silk-collagen Hydrogels for the Recovery of Contused Spinal Cord in Rats”
27. Biomaterials (2022년) (IF=15.304 , 상위 1.7%)
“Nanoceria-GO-intercalated multicellular spheroids revascularize and salvage critical ischemic limbs through anti-apoptotic and pro-angiogenic functions”
26. Bioactive Mater (2022년) (IF=16.874 , 상위 2%)
“Dendritic cell-mimicking scaffolds for ex vivo T cell expansion”
25. Biomaterials (2022년) (IF=15.304 , 상위 1.7%)
“Diabetic bone regeneration with nanoceria-tailored scaffolds by recapitulating cellular microenvironment: Activating integrin/TGF-β co-signaling of MSCs while relieving oxidative stress”
24. Bioactive Mater (2022년) (IF=16.874 , 상위 2%)
“Materials and extracellular matrix rigidity highlighted in tissue damages and diseases: Implication for biomaterials design and therapeutic targets”
23. Adv Health Mater (2022년) (IF=11.092 , 상위 8%)
“Mimicking Bone Extracellular Matrix: From BMP-2-Derived Sequences to Osteogenic-Multifunctional Coatings”
22. Bioeng. Trans. Med. (2022년) (IF=10.684 , 상위 11%)
“Hyperelastic, shape-memorable, and ultra-cell-adhesive degradable polycaprolactone-polyurethane copolymer for tissue regeneration”
21. Bioactive Mater (2022년) (IF=16.874 , 상위 2%)
“Multifunctional GelMA platforms with nanomaterials for advanced tissue therapeutics”
20. Science Adv. (2021년) (IF=14.980 , 상위 5%)
“Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy”
19. Biomaterials (2021년) (IF=15.304 , 상위 1.7%)
“Dual actions of osteoclastic-inhibition and osteogenic-stimulation through strontium-releasing bioactive nanoscale cement imply biomaterial-enabled osteoporosis therapy”
18. Signal Trans Target Therapy (2021년) (IF=38.120 , 상위 1.3%)
“Spatiotemporal control of CRISPR/Cas9 gene editing”
17. Biomaterials (2021년) (IF=15.304 , 상위 1.7%)
“Electricity auto-generating skin patch promotes wound healing process by activation of mechanosensitive ion channels”
16. Biomaterials (2021년) (IF=15.304 , 상위 1.7%)
“Therapeutic tissue regenerative nanohybrids self-assembled from bioactive inorganic core / chitosan shell nanounits”
15. J. Hepatology (2021년) (IF=30.083 , 상위 2.9%)
“Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease”
14. Chem. Eng. J. (2021년) (IF=16.744 , 상위 3%)
“Optimally dosed nanoceria attenuates osteoarthritic degeneration of joint cartilage and subchondral bone”
13. Biomaterials (2021년) (IF=15.304 , 상위 1.7%)
Antibacterial, proangiogenic, and osteopromotive nanoglass paste coordinates regenerative process following bacterial infection in hard tissue
12. Prog. Mater. Sci. (2020년) (IF=48.165 , 상위 0.8%)
Materials roles for promoting angiogenesis in tissue regeneration
11. Biomaterials (2020년) (IF=15.304 , 상위 1.7%)
Protein-reactive nanofibrils decorated with cartilage-derived decellularized extracellular matrix for osteochondral defects
10. Adv. Funct. Mater. (2020년) (IF=19.924 , 상위 5.5%)
“Molecularly Imprinted Polymers and Electrospinning: Manufacturing Convergence for Next-Level Applications”
9. J. Clinical Investigation (2020년) (IF=19.477 , 상위 1.4%)
“Epithelial splicing regulatory protein 2–mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis”
8. Biomaterials (2020년) (IF=15.304 , 상위 4%)
“Revascularization and limb salvage following critical limb ischemia by nanoceria-induced Ref-1/APE1-dependent angiogenesis”
7. Biomaterials (2020년) (IF=15.304 , 상위 1.7%)
“Hierarchical microchanneled scaffolds modulate multiple tissue-regenerative processes of immune-responses, angiogenesis, and stem cell homing”
6. Biomaterials (2019년) (IF=15.304 , 상위 1.7%)
“Anti-inflammatory action of folate-functionalized bioactive ion-releasing nanoparticle imply drug-free nanotherapy of inflamed tissue”
5. PNAS (2019년) (IF=12.779/ 상위 7.4%)
“Implantable multireservoir device with stimulus-responsive membrane for on-demand and pulsatile delivery of growth hormone”
4. Mater Horizons (2019년) (IF= 15.717 / 상위 5.7%)
“Carbon based-nanomaterials as an emerging platform for theranostics”
3. Biomaterials (2019년) (IF=15.304 / 상위 1.7%)
“Role of nuclear mechanosensitivity in determining cellular responses to forces and biomaterials”
2. Adv Drug Deliv Rev (2019년) (IF=17.873 / 상위 1.4%)
“Advanced drug delivery systems and artificial skin grafts for skin wound healing”
1. Biomaterials (2018년) (IF=15.304 / 상위 1.7%)
“Nanocements produced from mesoporous bioactive glass nanoparticles.”